Nucleate UK x HSBC Innovation Banking: The Next Wave of UK Discovery
The UK has long been a global leader in early-stage discovery, but as capital shifts toward de-risked assets and later-stage deals, how do we keep novel biology fundable and buildable? This event brings together investors, founders, and scientists to explore the capital models, company-building approaches, and emerging infrastructure shaping the next generation of UK biotech.
Register here to confirm your availability and receive a calendar invite.
Time: 14:30 – 20:00 BST, Wednesday 15th April
Agenda:
14:30 – Registration
15:00 – Welcome address
15:20 – Panel: Capital Models for Novel Biology
16:00 – Panel: Funding AI Infrastructure in Translational Biology
16:40 – Refreshment break
17:10 – Fireside chat keynote
17:30 – Frontier Innovation Showcase
18:00 – Closing remarks and Networking Session
Speakers:
Who Funds First-In-Class? Capital Models for Novel Biology
- Nathaniel Dahan | Senior Associate, Syncona
- Melisa Guven | Principal, Monograph Capital
- Aseem Ghaghda | Senior Associate, Sofinnova Partners
- Jacqueline Fok | Investment Director, Softbank Vision Fund
Putting a Price on Data: Funding AI Infrastructure in Translational Biology
- Melissa Strange | CFO, Bind Research
- Glen Gowers | Co-founder and CEO, Basecamp Research
- Jake Taylor-King | Co-founder, Relation Therapeutics
Fireside chat with Professor Simon Boulton - Founder & CSO, ALTX Therapeutics Ltd.; Co-founder, Artios Pharma Ltd; Chief Translation Advisor, CRUK
Frontier Innovation Showcase featuring cutting-edge research from UK academic labs:
- Gabriele Lignani | UCL | Co-founder, Epilepsy GTx
- Pietro Sormanni | Imperial College London
- Rachael Pearson | King's College London
About the Host:
Nucleate is a 501(c)(3) nonprofit organisation dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratise biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.org for more information, and visit https://nucleate.org/privacy-policy/ to read our privacy policy. We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!
For information on our sponsors visit: https://nucleate.org/sponsors/